Both in Biotechnology
Lineage Cell Therapeutics vs Century Therapeutics
Over the past year LCTX returned −42.8% and IPSC returned +191.4%; their daily moves had a correlation of 0.25.
LCTX −42.8% IPSC +191.4%Growth of $1, one year, split-adjusted
| Metric | LCTX | IPSC |
|---|---|---|
| Price | $1.03 | $1.67 |
| Market cap | $260.5M | $302.4M |
| Today | +1.98% | +9.87% |
| 1 month | +9.8% | +26.5% |
| 6 months | −28.0% | −28.6% |
| Year to date | −38.3% | +67.9% |
| 1 year | −47.4% | +178.3% |
| Revenue growth (YoY) | −61.3% | — |
| Gross margin | 100.0% | — |
| Net margin | 138.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 19.9× | — |
| Net cash | $50.8M | $119.7M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 75.0% |
| Short % of float | 12.9% | 23.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).